Evidence map›Paper›PMID 38351173›Full record

ReviewMolecular psychiatry2024

Psychosis superspectrum II: neurobiology, treatment, and implications.

Roman Kotov, William T Carpenter, David C Cicero, Christoph U Correll, Elizabeth A Martin, Jared W Young, David H Zald, Katherine G Jonas

Abstract readReview
In one paragraph

Review in Molecular psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Roman KotovDepartment of Psychiatry and Behavioral Health, Stony Brook University, Stony Brook, NY, USA. roman.kotov@stonybrook.edu.ORCID 0000-0001-9569-8381
William T CarpenterDepartment of Psychiatry, University of Maryland, Baltimore, MD, USA.
David C CiceroDepartment of Psychology, University of North Texas, Denton, TX, USA.
Christoph U CorrellDepartment of Psychiatry, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA.
Elizabeth A MartinDepartment of Psychological Science, University of California, Irvine, Irvine, CA, USA.
Jared W YoungDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.
David H ZaldRutgers University, The State University of New Jersey, New Brunswick, NJ, USA.
Katherine G JonasDepartment of Psychiatry and Behavioral Health, Stony Brook University, Stony Brook, NY, USA.ORCID 0000-0002-1910-223X

Funding

Trajectories of Aging in Psychotic Disorders Over 27 YearsR01MH110434 · NIMH · STATE UNIVERSITY NEW YORK STONY BROOK · PI KOTOV, ROMAN I · 2016 to 2020
$4.5M
Spanish Adaptation of Negative Valence MeasuresR01MH122537 · NIMH · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI KOTOV, ROMAN I, SIMMS, LEONARD JAY · 2021 to 2024
$3.1M
Trajectories and Determinants of Cognitive Decline in Psychotic Disorders Over 35 YearsR01MH135119 · NIMH · STATE UNIVERSITY NEW YORK STONY BROOK · PI Katherine G Jonas, Roman I Kotov · 2024 to 2026
$2.3M
Trajectories of recovery from psychosis over two decadesR01MH094398 · NIMH · STATE UNIVERSITY NEW YORK STONY BROOK · PI KOTOV, ROMAN I · 2011 to 2013
$2.2M
Improving the Precision of Genetic Markers for Psychotic DisordersK08MH122673 · NIMH · STATE UNIVERSITY NEW YORK STONY BROOK · PI JONAS, KATHERINE G · 2020 to 2023
$782k
Optimized Phenotypes for Genetic Association StudiesR21MH123908 · NIMH · STATE UNIVERSITY NEW YORK STONY BROOK · PI JONAS, KATHERINE G · 2020 to 2020
$448k
NIMH NIH HHS K08 MH122673NIMH NIH HHS R01 MH094398NIMH NIH HHS R01 MH110434NIMH NIH HHS R01 MH122537NIMH NIH HHS R21 MH123908U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) R01MH122537
6 · The paper itself

Abstract

Alternatives to traditional categorical diagnoses have been proposed to improve the validity and utility of psychiatric nosology. This paper continues the companion review of an alternative model, the psychosis superspectrum of the Hierarchical Taxonomy of Psychopathology (HiTOP). The superspectrum model aims to describe psychosis-related psychopathology according to data on distributions and associations among signs and symptoms. The superspectrum includes psychoticism and detachment spectra as well as narrow subdimensions within them. Auxiliary domains of cognitive deficit and functional impairment complete the psychopathology profile. The current paper reviews evidence on this model from neurobiology, treatment response, clinical utility, and measure development. Neurobiology research suggests that psychopathology included in the superspectrum shows similar patterns of neural alterations. Treatment response often mirrors the hierarchy of the superspectrum with some treatments being efficacious for psychoticism, others for detachment, and others for a specific subdimension. Compared to traditional diagnostic systems, the quantitative nosology shows an approximately 2-fold increase in reliability, explanatory power, and prognostic accuracy. Clinicians consistently report that the quantitative nosology has more utility than traditional diagnoses, but studies of patients with frank psychosis are currently lacking. Validated measures are available to implement the superspectrum model in practice. The dimensional conceptualization of psychosis-related psychopathology has implications for research, clinical practice, and public health programs. For example, it encourages use of the cohort study design (rather than case-control), transdiagnostic treatment strategies, and selective prevention based on subclinical symptoms. These approaches are already used in the field, and the superspectrum provides further impetus and guidance for their implementation. Existing knowledge on this model is substantial, but significant gaps remain. We identify outstanding questions and propose testable hypotheses to guide further research. Overall, we predict that the more informative, reliable, and valid characterization of psychopathology offered by the superspectrum model will facilitate progress in research and clinical care.

Indexed as

NeurobiologyPsychotic DisordersHumansPsychopathologyReproducibility of Results

Identifiers

PMID38351173
PMCPMC11731826

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.